New York Blood Center Inc is a 501(c)(3) organization based in New York, New York, registered in 1961, with $605,770,964 in FY2024 revenue. CharityIndex grades it A, and it directs about 78% of spending to programs.
Revenue (FY2024)
$605.8M
▲ 7.3% vs prior year
Health median: $840K
Expenses (FY2024)
$652.7M
Net assets
$555.5M
Employees
3,358
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For New York Blood Center Inc: 78% to programs · $5 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For New York Blood Center Inc: 10 mo reserves · -8% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For New York Blood Center Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For New York Blood Center Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
As one of the most preeminent and comprehensive blood centers in the world, new york blood center operates under a four-part mission.specifically, nybc exists:- to provide the highest quality blood and stem cell products and related medical and consultative services to hospitals and patients.- to conduct the highest quality, novel and innovative research in the fields of hematology, blood banking and transfusion medicine, and cellular therapies, thus advancing these fields and positively impacting the public health- to develop products, technologies, and services in the fields of hematology, blood banking, and transfusion medicine and cellular therapies, with the potential to have worldwide humanitarian impact- to train the next generation of leaders in each of these fields
Medical programs: (1) hemophilia services consortium,(2) comprehensive cell solutions (includes apheresis/transfusion services and contract manufacturing), (3) bone marrow program, and (4) national cord blood program (collection, processing, and storage of cord blood units and distribution of these units for treatment or research purposes)
Research program: the new york blood center operates awide-ranging program of research into the properties of blood andblood related diseases.
Revenue grew from $320.3M (FY2013) to $605.8M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
-7.8%
Spent more than it raised in the latest fiscal year.
Total assets
$884.7M
Total liabilities
$329.2M
Net assets
$555.5M
Salaries & benefits
$267.6M
41% of expenses
Board members
17
16 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $605,770,964▲7.3% | $652,737,231▲8.9% | $555,484,136▼0.4% | $884,660,660▲12.8% | 990 |
| 2023 | $564,818,942▲2.6% | $599,527,174▲9.4% | $557,858,549▲1.1% | $784,292,844▲2.3% | 990 |
| 2022 | $550,372,782▲40.4% | $548,147,084▲41.4% | $551,652,853▼7.7% | $766,718,159▼6.4% | 990 |
| 2021 | $392,002,693▼29.3% | $387,704,513▼23.5% | $597,919,948▲7.7% | $819,022,618▲25.3% | 990 |
| 2020 | $554,715,818▲14.7% | $507,094,985▲5.0% | $555,055,352▲30.8% | $653,903,495▲26.8% | 990 |
| 2019 | $483,523,813▲23.6% | $482,834,961▲24.5% | $424,306,958▼10.6% | $515,795,702▼6.8% | 990 |
| 2018 | $391,197,146▲10.9% | $387,919,716▲6.9% | $474,740,647▼2.0% | $553,444,220▼0.3% | 990 |
| 2017 | $352,613,347▲1.6% | $362,739,061▼2.3% | $484,255,859▲11.1% | $555,190,471▲7.6% | 990 |
| 2016 | $346,938,101▲3.6% | $371,108,793▲10.4% | $435,806,543▲8.5% | $515,751,776▲9.9% | 990 |
| 2015 | $334,892,050▲4.6% | $336,026,190▲4.6% | $401,754,370▼3.7% | $469,404,674▼2.3% | 990 |
| 2014 | $320,265,446 | $321,213,900▲0.2% | $417,331,844▲4.3% | $480,638,846▲2.0% | 990 |
| 2013 | $320,273,754 | $320,611,013▼2.2% | $400,190,321▲3.3% | $471,298,905▲2.6% | 990 |
| 2012 | — | $327,695,000▼2.3% | $387,394,000▲1.8% | $459,201,000▼0.1% | 990 |
| 2011 | — | $335,455,000▼6.8% | $380,389,000▼1.9% | $459,496,000▼3.0% | 990 |
| 2010 | — | $360,078,000 | $387,783,000 | $473,629,000 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Christopher D Hillyer — $2,527,854 (0.39% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Christopher D Hillyer | President & Chief Executive Officer | 50 | $2,527,854 |
| Joseph Mohr | Evp, Chief Business Officer | 50 | $866,948 |
| Jed Gorlin | Vp, Medical & Regulatory Affairs | 50 | $797,834 |
| David Bench | Evp, Chief Financial Officer | 50 | $632,962 |
| Adrian David | Evp, Chief Operating Officer | 50 | $586,452 |
| Jordana Schwartz | Svp - General Counsel/secretary | 50 | $534,976 |
| Betsy Jett | Svp, Quality and Regulatory Affairs | 50 | $517,712 |
| Elizabeth Mcquail | Evp - Ops & Manufacturing/coo | 0 | $492,691 |
| Vaughn Ratchford | Svp, Chief Real Estate Officer | 50 | $477,427 |
| Bruce Sachais | Svp, Chief Medical Officer | 50 | $439,367 |
| Donna Strauss | Vp - Enterprise Laboratory Services | 50 | $435,711 |
| Meghan Wood | Vp, Ventures & Business Development | 50 | $430,660 |
| Richard Kiernan | Svp, Chief Human Resources Officer | 50 | $426,218 |
| Patricia Killeen | Svp, Logistics, Ops Excellence | 50 | $424,273 |
| David Graham | Svp Enterprise Donor Engagement | 50 | $421,850 |
| Andrea Cefarelli | Svp, Corporate Comm & Public Affairs | 50 | $401,362 |
| Jeannie Mascolino | Vp, Regional Operations (nybc) | 50 | $392,412 |
| Larry Luchsinger | Svp, Chief Scientific Officer | 50 | $351,498 |
| Eric Senaldi | Deputy Chief Medical Officer | 50 | $345,859 |
| Devin Blass | Svp, Comprehensive Cell Solutions | 50 | $337,981 |
| Contractor | Services | Paid |
|---|---|---|
| Consigli Construction Co Inc | Construction | $71,982,326 |
| Markham and Stein Unlimited LLC | Marketing Services | $4,634,263 |
| Incept Corporation | Blood Donor Marketing | $3,736,261 |
| Donald Holm Construction | Construction | $1,766,557 |
| Century Protective Services | Security Services | $1,741,913 |
64 grants to New York Blood Center Inc totaling $21.8M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| American Online Giving Foundation Inc | General support | 2024 | $23,821 |
| Charities Aid Foundation America | Charitable donation | 2024 | $8,305 |
| Delaware Community Foundation | Fit-out for bbd biotech plans at blood bank of delmarva newark location | 2023 | $4,535,926 |
| Trustees of Columbia University | Research | 2023 | $1,026,885 |
| Fred Hutchinson Cancer Center | Research support/subawards | 2023 | $651,016 |
| The Childrens Hospital of Philadelphia | Research | 2023 | $130,827 |
| Washington University | Research | 2023 | $130,427 |
| Scripps Research Institute | Grants for scientific research | 2023 | $39,472 |
| American Online Giving Foundation Inc | General support | 2023 | $23,738 |
| Family Health International | Hiv/ aids prevention | 2023 | $16,835 |
| Donor Advised Charitable Giving | Health | 2023 | $16,100 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $9,675 |
| Charities Aid Foundation America | Charitable donation | 2023 | $8,273 |
| Trustees of Columbia University | Research | 2022 | $1,540,022 |
| Delaware Community Foundation | Fit-out for bbd biotech plans at blood bank of delmarva newark location | 2022 | $1,501,591 |
2 grants totaling $20K in FY2021. All grants made by New York Blood Center Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| American Association of Blood Banks | Conference and expo sponsorship | $10,000 |
| American Association of Blood Banks | Conference and expo sponsorship | $10,000 |
Explore more
Data for New York Blood Center Inc (EIN 13-1949477) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.